Search

Search Constraints

You searched for: Author/Creator Suwiński, Rafał

Search Results

1. Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients. Issue 1 (February 2021)

2. BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma. Issue 5 (October 2020)

3. Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus‐positive oropharyngeal squamous cell carcinoma. Issue 3 (19th December 2018)

4. Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma. (19th May 2022)

5. High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors. Issue 5 (October 2018)

6. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment. Issue 3 (3rd June 2023)

7. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Issue 9 (September 2017)

8. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Issue 9 (September 2017)

9. The VEGFR2, COX‐2 and MMP‐2 polymorphisms are associated with clinical outcome of patients with inoperable non‐small cell lung cancer. Issue 10 (3rd June 2015)